UPDATE: Deutsche Bank Initiates Coverage On Ligand Pharmaceuticals On Growing Royalty Play On Biopharma
December 02, 2014 at 08:05 AM EST
In a report published Tuesday, Deutsche Bank analyst Gregg Gilbert initiated coverage on Ligand Pharmaceuticals Inc. (NASDAQ: LGND) with ...